USFDA-Guideline Based Validation of Testing Method for Ciprofloxacin in Indonesian Serum Specimen
Regarding a new regulation from Indonesia FDA (Badan POM-RI), all new non patent drugsshould shown bioequivalence with the originator drug prior to registration. Bioequivalence testing (BE-testing) has to be performed to the people that represented of population to which the drug to be administrated...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Conference or Workshop Item NonPeerReviewed |
| 語言: | English |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | https://repository.ugm.ac.id/275152/1/ICS%20Tri%20joko.pdf https://repository.ugm.ac.id/275152/ |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|